Aurobindo Pharma gets USFDA nod for infections treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspension 100 mg /5 mL and 200 mg/5 mL. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

Delhi HC seeks Centre's reply on plea to take action against online pharmacies
The petition came up for hearing before Justice Vibhu Bakhru which listed it for further proceedings on February 25 next year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2018 Category: Pharmaceuticals Source Type: news

Bank fraud: ED attaches Rs 5.4-cr assets in Gujarat pharma firm case
The attached immovable properties, one each in Faridabad and Gurgaon, belong to Delhi-based businessman Gagan Dhawan, who was arrested by the ED and is out on bail. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for breast cancer drug
The company said it will manufacture the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2018 Category: Pharmaceuticals Source Type: news

US may dilute norm used to delay generics
The move, if successful, is expected to help Indian companies gain easier access to the world ’s biggest pharma market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2018 Category: Pharmaceuticals Source Type: news

Sreedhareeyam targets a turnover of Rs 300 crore in 5 years
The group vice chairman Hari N Nampoothiri said the group will increase its number of branches from the present 23 to 100 in the next five years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2018 Category: Pharmaceuticals Source Type: news

E-Pharma companies want more clarity on data sharing, localisation draft rules
The health ministry had on August 28 published the draft guidelines for e-pharma companies, giving stakeholders 45 days to make suggestions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2018 Category: Pharmaceuticals Source Type: news

Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for USD 10.28 mn
The acquisition will enable the company to commercialise its registered generics drug products in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2018 Category: Pharmaceuticals Source Type: news

MedAchievers partners with Venture India to launch $100 million healthcare fund
MedAchievers, in the last four years, have supported startups in six geographies including the United Kingdom and Australia, he added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma expects normalisation of India business in FY'19
Sun Pharma MD Dilip Shanghvi said the government's enforced price cuts and policy changes are potential risk factors for the business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 2, 2018 Category: Pharmaceuticals Source Type: news

Skin ailments augment derma business in retail pharma
Increasing incidence of fungal infections, greater awareness of skin-related issues and skin care and a growing desire to look presentable are factors driving the growth, say experts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's terminates Armis Biopharma's investigation license of DFA-02
​According to a press release issued by the Indian drug maker, as a result of the termination, Dr Reddy's has regained worldwide rights to DFA-02, and is currently evaluating its options to take the programme forward. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2018 Category: Pharmaceuticals Source Type: news

Mankind Pharma eyes $1 billion topline by 2021
The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD 10 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2018 Category: Pharmaceuticals Source Type: news

Mukesh Rathi uses digital to give Dr. Reddy ’s a competitive edge
The metric that we use to gauge the success of our digital initiatives is the eventual business benefit that it delivers to the organization, Says Rathi (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2018 Category: Pharmaceuticals Source Type: news

Post-Johnson & Johnson, government plans law to put onus on medical companies
The adverse event also has certain riders that it has not been reported earlier (by other patients) when the device was under clinical trial and is not part of the package insert (leaflet) of the device. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2018 Category: Pharmaceuticals Source Type: news

Australian Competition and Consumer Commission clears Arrow and Apotex merger: Strides
In May 2018, Strides Pharma Science Ltd announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 20, 2018 Category: Pharmaceuticals Source Type: news

CCI probe finds unfair practices by three drug companies
The competition regulator has started hearing the matter and a verdict is likely to be out soon, the official said. After the hearing, the watchdog may also order further probe. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 19, 2018 Category: Pharmaceuticals Source Type: news

‘Pharma firms in 16 nations evading tax of $3.8 billion/year'
The report explained how two Pfizer subsidiaries in Singapore, a tax haven, earned a profit of $2.1 million in 2014 on revenues of $4.3 billion, a rate of over 49%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 19, 2018 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo moves NCLT to stay insolvency plea against RHC Holding
A two member bench NCLT has asked both - RHC Holding and its lender HDFC Bank to file reply over the move within a week. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 18, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets nod from South African health authority for HIV drug
The approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of millions of patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 18, 2018 Category: Pharmaceuticals Source Type: news

Sun marches ahead with its specialty pipeline, announces European approval for Tildra
In the last two months Sun Pharma has received approval for four drugs from its pipeline after a dry spell of nearly 2 years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 18, 2018 Category: Pharmaceuticals Source Type: news

Daiichi intervenes in HDFC ’s insolvency case against Singh brothers
The National Company Law Tribunal has directed HDFC and the holding company, RHC Holding, to respond to Daiichi's plea before the next hearing on October 4, said lawyers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 18, 2018 Category: Pharmaceuticals Source Type: news

SC exempts Saridon, Piriton Expectorant from government's ban list
GSK confirmed the development, while ET is awaiting response to queries sent to Piramal about the development. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 17, 2018 Category: Pharmaceuticals Source Type: news

Wockhardt moves HC against ban on its fixed dose combination drug
Wockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7 notification banning 328 such combinations (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 14, 2018 Category: Pharmaceuticals Source Type: news

NCLT allows Shivinder Mohan Singh to withdraw plea against elder brother Malvinder Singh
However, a counsel for Religare Enterprises, which was also a respondent in the case, said there were allegations against the company of siphoning off funds by the Singh brothers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 14, 2018 Category: Pharmaceuticals Source Type: news

How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma company
Aurobindo has leapfrogged to become the second-largest generics player in the US and is closing in on Israel ’s Teva, the largest generic drug manufacturer worldwide. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Health ministry to ban 328 combination medicines over safety concerns
ET has viewed parts of the latest ban notifications, which a senior ministry official confirmed would be notified this week. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2018 Category: Pharmaceuticals Source Type: news

J & J case: Government asks 'victims' to approach central or state panel
If the affected patients approach the state-level committee, they may write to the concerned state drug controller who will be the member secretary of the state-level committee. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2018 Category: Pharmaceuticals Source Type: news

USFDA conducting inspection of Mohali plant: Sun Pharma
The inspection by the United States Food and Drug Administration (USFDA) started on September 10, 2018 and is ongoing, Sun Pharma said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 11, 2018 Category: Pharmaceuticals Source Type: news

Despite spending big on legal & professional consultants, FDA woes continue to haunt pharma companies
Sun Pharma ’s Halol plant received four observations three months after it received the clearance from the USFDA that had ended a two-year import ban. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 11, 2018 Category: Pharmaceuticals Source Type: news

Supreme Court prescribes pain relief for 15 banned combination drugs
The order effectively brings several popular cough syrups, painkillers and cold medication out of the health ministry ’s impending ban list, providing relief to drug companies pegged at over Rs 740 crore annually. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 8, 2018 Category: Pharmaceuticals Source Type: news

USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu
"The United States Food and Drug Administration (USFDA) has conducted an inspection at our sterile injectable site (CP-IV) located at Gummudipoondi from August 30 to September 06, 2018," Caplin Point Laboratories said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma gets 6 observations by USFDA for its Halol facility
"At the conclusion of the inspection, the agency issued a Form 483, with six observations," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2018 Category: Pharmaceuticals Source Type: news

Malvinder, Godhwani colluded to divert Rs 1,223 crore from Religare and Fortis
Additionally, Malvinder Singh forged the signature of Aditi S Singh, wife of Shivinder Singh, in RHC documents, according to the petition. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2018 Category: Pharmaceuticals Source Type: news

Drones set to fly in as lifesavers in rural India
A startup, Air Aid Pvt Ltd, that will use drones to transport blood, vaccines and emergency medicines to people and hospitals living in rural areas from mid-2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2018 Category: Pharmaceuticals Source Type: news

Lupin to train over 1,000 graduates for pharma industry
Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash deal
The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US for Aurobindo. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2018 Category: Pharmaceuticals Source Type: news

Delhi High Court orders release of Rs 9 crore to Daiichi as first payment in Rs 3,500-crore arbitration award
Malvinder Singh had allegedly sold 45 lakh units held in RHT for around 3.5 million Singapore dollars towards payment of an EMI on a property in Singapore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Delhi High Court raps Malvinder Singh for selling assets in Singapore Trust
Malvinder Singh had allegedly sold 45 lakh units held in RHT for around 3.5 million Singapore dollars towards payment of an EMI on a property in Singapore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Gland Pharma seeks pitches from investment bankers to go public
Gland Pharma, which is owned 74% by the Chinese major, is seeking a valuation of $3 billion, which is more than twice that of the valuation it was bought in September 2017. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2018 Category: Pharmaceuticals Source Type: news

India's oxytocin ban delayed by a month as Delhi HC hears cases against it
Oxytocin is a hormone drug used to induce labour in pregnant women and stall post-partum bleeding. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2018 Category: Pharmaceuticals Source Type: news

Domestic pharmaceutical players eye Bharat Serums acquisition
The two funds together hold a 23% stake and the remainder is with the Daftary family. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2018 Category: Pharmaceuticals Source Type: news

Domestic pharma players eye Bharat Serums acquisition
The two funds together hold a 23% stake and the remainder is with the Daftary family. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2018 Category: Pharmaceuticals Source Type: news

Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western Europe
This is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod to market its postherpetic neuralgia drug
The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 28, 2018 Category: Pharmaceuticals Source Type: news

India's health ministry still 'deliberating' on findings on J & J's faulty hip implants, says JP Nadda
J&J, through subsidiary DePuy Orthopaedics, had issued a global recall of the implant system, called ASR Hip System, in 2010 after it received "new information" from the UK National Joint Registry, a J&J spokesperson earlier said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 28, 2018 Category: Pharmaceuticals Source Type: news

Modicare: Rule of hospital stay eased for cancer fighters
Guidelines of the tumour board have been adopted to ensure patients do not have to pay out of their pocket. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 28, 2018 Category: Pharmaceuticals Source Type: news

USFDA conducts inspection of Sun Pharma ’s Halol site: Sources
The USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2018 Category: Pharmaceuticals Source Type: news

Lupin launches contraceptive drug in the US market
The company has launched the product in the US after having received approval from the USFDA earlier, Lupin said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2018 Category: Pharmaceuticals Source Type: news

BRS Group highest bidder for SevenHills hospital
Despite being endorsed by a Bollywood superstar, SevenHills failed to take off in Mumbai on the back of poor location and mismanagement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2018 Category: Pharmaceuticals Source Type: news